Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Control antibody rhesus IgG1 (anti-DSP) [DSPR1]

Control antibody rhesus IgG1 (anti-DSP) [DSPR1]
Product Type: Controls and Anti-Infectives
Format: Anti-desipramine, DSPR1, rhesusized variable region, rhesus IgG1 Fc
Clone ID: [DSPR1]
RRID: AB_2716330
Common Names: Control antibody rhesus IgG1 (anti-DSP) [DSPR1] | Control antibody: Rhesus recombinant IgG1 Anti-DSP | PR-1117 | NHP14 | aDSP_rz_G1k_mamu | CAT-00193
Target: DSP
Reactivity:
Applications: in vivo in vivo; controls
Description:

*Manufactured-On-Demand*   

DSPR1: Rhesus IgG1-kappa with CDRs grafted from an irrelevant (anti-desipramine) monoclonal antibody. Serves as a control antibody for other rhesus recombinant antibodies.
Modifications: None
Restrictions: No
Sponsor: NIAID
How to cite (Methods): Control antibody rhesus IgG1 (anti-DSP) [DSPR1] (NHPRR Cat#PR-1117, RRID:AB_2716330)
How to cite (Acknowledgments): The Control antibody rhesus IgG1 (anti-DSP) [DSPR1] antibody (Cat#PR-1117, RRID:AB_2716330) used in this study was provided by the Nonhuman Primate Reagent Resource (NHPRR, RRID:SCR_012986), funded by NIAID U24 AI126683.

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2025